Release Date: 28/07/17 16:22 Summary: Quarterly Activities Report and Quarterly Cashflow Report Price Sensitive: Yes Download Document 2.88MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%